CareDx target price raised to $80 from $65
CDNA•Canaccord Genuity raised its target price for CareDx to $80 from $65.
Related News
Zealand Pharma reports ZP9830 well tolerated in Phase 1 multiple-dose trial
ZEAL•
Red Cat plans to acquire Steyr Motors for EUR 39 per share in cash
RCAT•
Solv Energy Inc: JP Morgan cuts target price to $34 from $43
MWH•
D.A. Davidson cuts Regions Financial target price to $31 from $32
RF•
Roche's divarasib outperforms approved rivals in Phase III lung cancer trial
RHHBY•